Inhibition of CD26 activity reduces the growth of wound-induced epidermal tumours, although it must be noted that CD26 is expressed by both epidermal and dermal cells and that during tumour progression there are dynamic changes in dermal CD26 expression [70]. The gene discussed is DPP4; the disease is neoplasm.